effects of stopping tirzepatide People Who Stopped Taking the Weight Loss Drug Regained Nearly Half the Weight They Lost Tirzepatide vs. Semaglutide: What You
Description
To make GLP-1s more accessible, we need bold new policies that shift the paradigm for controlling costs by moving from a high-margin, low-volume drug sales model to a high-volume, low-profit margin model
Long-acting GLP-1 RAs, such as semaglutide and dulaglutide, may exert a more pronounced inhibitory effect on gallbladder contraction due to their extended half-lives and sustained pharmacological profiles, thereby increasing the risk of gallbladder-related AEs (Trujillo et al., 2021)
Furthermore, to significantly strengthen the mechanistic understanding of how systemic SEM may reach the retina, further in vivo pharmacokinetic or in vitro permeability studies are required
Lancet North Am Ed 2019;394:12130
